Reunion Neuroscience Stock (NASDAQ:REUN)
Previous Close
$1.13
52W Range
$0.63 - $21.56
50D Avg
$1.02
200D Avg
$1.12
Market Cap
$13.12M
Avg Vol (3M)
$429.86K
Beta
4.20
Div Yield
-
REUN Company Profile
Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.